Cascade Wealth Advisors, Inc Vaxart, Inc. Transaction History
Cascade Wealth Advisors, Inc
- $177 Billion
- Q2 2025
A detailed history of Cascade Wealth Advisors, Inc transactions in Vaxart, Inc. stock. As of the latest transaction made, Cascade Wealth Advisors, Inc holds 25,035 shares of VXRT stock, worth $9,012. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,035Holding current value
$9,012% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VXRT
# of Institutions
97Shares Held
23MCall Options Held
66.1KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA10.4MShares$3.75 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$837,4930.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$638,7640.0% of portfolio
-
Marshall Wace, LLP London, X01.76MShares$634,9970.0% of portfolio
-
State Street Corp Boston, MA851KShares$306,4020.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $45.5M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...